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Abstract
Prior to the COVID-19 pandemic, facilitated telemedicine encounters were available at outreach locations; however, our
tertiary children’s hospital had not invested widely in direct to patient telemedicine. Our daily pediatric subspecialty visits
dropped from an average of 2066 visits a day prior to COVID-19 in our community to 1000 patients a day during the
study period. Over the four-week period from April 15 to May 12, 2020, patient and family experience ratings of
percentage of positive responses (9 or 10) on the provider rating 0-10 scale between telemedicine and in-person visits
were compared for our pediatric subspecialty clinics using a Pearson’s Chi Squared test, p-value <0.05 determined
significance. Several process measures were compared using the same method. Total visits conducted via telemedicine
and survey response rates were calculated with frequencies and percentages. Of the 14,428 subspecialty visits attended,
10,135 (70.2%) were telemedicine. Developmental and Behavioral Medicine saw the highest proportion of patients
(99.5%) via telemedicine while Cystic Fibrosis, Dentistry, and Neurosurgery saw no telemedicine patients. Telemedicine
visits yielded a 6.5% higher survey response rate than in-person visits. Overall rating of 9 or 10 for telemedicine visits
was 87.9%, compared to 83.9% for in-person visits (p-value = 0.07). All process measures scored higher in telemedicine
visits. This may reflect telemedicine visits’ ability to improve the efficiency of care delivery: removing the need to travel,
park, navigate the building, register for the visit, obtain vital signs and wait for the provider.
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Introduction
The public health crisis of COVID-19 caused a large
decline in outpatient clinic visits starting in early March
with the highest sustained decrease in outpatient visits for
pediatric care.1 In response, practices across the country
increased their use of telemedicine.1 Indeed, April 2020
saw a 50% increase in telemedicine use nationally. 2 As a
tertiary children’s hospital with over 35 subspecialties,
telemedicine had not been an option for most of our
patients with less than 4% of all outpatient visits
conducted via a telehealth platform. Most subspecialties
were experiencing a steady growth in facilitated telemedicine
visits. These were telehealth services at our regional
outreach centers that were supported by a specially trained
nurse tele-facilitator. The tele-facilitator ensured
exceptional communication between the provider off-site
and patient and family on-site. They initiated the
encounter, managed the interface between doctor and
patient (including the hands-on physical assessment) and
addressed technical challenges. However, due to social
distancing requirements and visitor restrictions in the
hospital and clinic settings, a direct to patient telemedicine
platform was necessary to fulfill the volume of patient
visits scheduled during the height of the COVID-19
pandemic.

This study evaluates the patient experience ratings for
direct to patient telemedicine pediatric specialty encounters
in comparison to in-person visits during a four-week
period during the COVID-19 pandemic.

Methods
Setting and Participants

This tertiary children’s hospital in the center of the United
States typically has over 200,000 specialty clinic visits per
year. Each encounter receives a patient experience survey
after their visit, so long as they do not fall within the
exclusionary rules. Exclusion rules include patients who
have received a survey for another encounter from the
enterprise within the last 14 days, patients who have
previously requested not to be surveyed or patients who
are not living with a parent or permanent guardian.

Data Collection

A nationally validated survey was administered, one for
telemedicine and the other for in-person visits.3,4
Telemedicine surveys were administered via two modes:
email and interactive voice response (IVR), a
computerized phone call. Some in-person specialty visits
also utilized text messaging (SMS) as a survey delivery
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modality in place of IVR. Each family received up to three
attempts for survey completion. Families first received an
email, or an IVR if an email address was not logged within
the electronic medical record immediately upon
discharging the encounter. If the family did not respond, a
phone call was queued between 6:00pm-8:00pm two days
after the encounter. If the family did not respond to the
first two attempts, one final phone or text outreach was
made again between 6:00pm-8:00pm the following day.
Phone calls left a voicemail with callback instructions, so
patients and families may complete the survey from the
details left in the voicemail. The text message provided a
link to an online survey, the same as the email link. The
survey was available for 14 days and then expired.

Exposure

Direct to patient telemedicine visits were instituted via the
Microsoft Teams platform (Version 1.3.00.9271). Patients
and their caregivers had to be physically located in either
Kansas or Missouri and the provider was most often
conducting the telemedicine visit from their own home.

Outcome Measures

The primary outcome measure was percent of 9 or 10
scores (“positive responses”) on the overall rating
measured by the question, “Using any number from 0 to
10, where 0 is the worst provider possible and 10 is the
best provider possible, what number would you use to rate
this provider?” Percent positive responses for specialty
telemedicine visits were compared to in-person visits for
four weeks (April 15 – May 12, 2020).
The secondary outcome measures were top box responses
(“yes, definitely” on a four-point Likert scale) for six
measures in two categories: person-centered and process.
The person-centered category evaluated aspects of the
relationship with the provider: getting enough information,
active listening, trust in the provider and knowledge of the
child’s medical history. The process questions for both
surveys included timeliness of meeting with the provider
and if the family knew what to do if they had questions.
The telemedicine survey also had two questions about ease
of connecting via the telemedicine platform and if they
would recommend telemedicine to family and friends.
Both surveys also included a final qualitative open-ended
question to gather comments (Box 1).

Box 1. Survey questions and rating scales
TELEMEDICINE VISIT
Question Text

Response Scale

Using any number from 0 to 10, where 0 is the worst
provider possible and 10 is the best provider
possible, what number would you use to rate this
provider?

Outcome
0; 1; 2; 3; 4; 5; 6; 7; 8; 9; 10
Worst
Best
Provider Possible
Provider Possible

Did this provider give you enough information
about your child's health and treatment?

Person-Centered
No; Yes, Somewhat; Yes, Mostly;
Yes, Definitely

Did the care provider listen carefully to you?
Did you trust the care providers with your child's
care?
Did the care provider seem to know your child’s
medical history?
Were you able to talk to a care provider in a timely
manner?
Did you know what to do if you had more questions
after your visit?
Was this method of connecting with a care provider
easy to use?
How likely would you be to recommend Telehealth
to your family and friends?

What else would you like to say about your
experience?
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No; Yes, Somewhat; Yes, Mostly;
Yes, Definitely
No; Yes, Somewhat; Yes, Mostly;
Yes, Definitely
No; Yes, Somewhat; Yes, Mostly;
Yes, Definitely
Process
No; Yes, Somewhat; Yes, Mostly;
Yes, Definitely
No; Yes, Somewhat; Yes, Mostly;
Yes, Definitely
No, Yes somewhat, Yes mostly,
Yes definitely
0; 1; 2; 3; 4; 5; 6; 7; 8; 9; 10
Not at all
Extremely
likely
likely
Qualitative
NA

IN-PERSON VISIT
Question Text
Using any number from 0 to 10,
where 0 is the worst provider
possible and 10 is the best provider
possible, what number would you
use to rate this provider?
Did the care providers give you
enough information about your
child's health and treatment?
Did the care providers listen
carefully to you?
Did you trust the care providers
with your child's care?
Did the care providers seem to
know your child's medical history?
Was your child seen by a care
provider in a timely manner?
Did you know what to do if you had
questions after your visit?

What else would you like to say
about your experience?
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Data Analysis

Data were entered into Microsoft Excel (Version
16.0.11929.20436). Pearson’s Chi Squared test for
significance with p-value <0.05 was used to compare the
percent positive responses for overall rating between
telemedicine and in-person subspecialty visits from April
15 to May 12, 2020. The same method was used to
compare the top box scores for process measures between
telemedicine and in-person visits. Descriptive statistics
were used to show percent of visits within a specialty clinic
type to be delivered via telemedicine and returned surveys.
The Institutional Review Board at Children’s Mercy
Kansas City deemed this non-human subject research.

Results
The impact of COVID-19 on attendance of clinic visits is
displayed in Figure 1. The average daily attendance for
clinic attendance from March 9-13, 2020 was 2066 patients
per day. This number dropped precipitously the following
week, and direct to patient telemedicine visits were
instituted the week after (blue bars).(Figure 1) When the
telemedicine patient experience surveys began on April 15,
2020, telemedicine visits were 62.2% of the daily visit
volumes.

Over the four-week period from April 15, 2020 to May 12,
2020, a total of 15,562 visits were attended, 4370 in-person
and 11,192 (71.9%) via telemedicine.(Table 1) Variability
existed by specialty for the percentage of patients seen via
telemedicine. Developmental and Behavioral Medicine saw
1582 patients via telemedicine (99.5% of all their visits),
followed by Sleep with 304 telemedicine visits (99.3%) and
Weight Management with 170 telemedicine visits (98.3%).
Hematology/Oncology saw the fewest percentage of their
patients via telemedicine (n=74, 11.5%), followed by
Ophthalmology (n=66, 25.9%) and Orthopedics (n=369,
27.8%). Three clinics – Cystic Fibrosis, Dentistry and
Neurosurgery – saw no telemedicine patients.
Response rates to the patient experience survey after an
encounter varied by appointment type and specialty (Table
2). Telemedicine encounter response rates were slightly
higher than in-person visits. Of the 2,129 telemedicine
visits sampled during the study timeframe, 628 responded
for a response rate of 29.2% (23.5% via email and 76.5%
via IVR). Of the 3,173 families surveyed for in-person
visits, 603 responded for a response rate of 26.1% (20.7%
via email, 0.3% via SMS, and 79.0% via IVR). The
response rates varied among subspecialties with larger
variability for the in-person visit type (telemedicine 14.3%
- 43.8%, in-person 0% - 38.4%).

Figure 1 Daily pediatric specialty encounter volumes by visit type
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Table 1. Encounter data by visit type and specialty, April 15 – May 12, 2020

Specialty
ADHD
Adolescent
Allergy
Cardiology
Child & Family Therapy
Cystic Fibrosis
Dental
Dermatology
Developmental & Behavioral
Eating Disorders
Endocrine
ENT
Genetics
GI
Gynecology
Hearing & Speech
Hematology/Oncology
Infectious Diseases
Nephrology
Neonatal Follow-Up
Neurology
Neurosurgery
Nutrition
Ophthalmology
Orthopedics
Pain Management
Plastic Surgery
PT/OT
Pulmonology
Rehabilitation Medicine
Rheumatology
Sleep
Surgery
Urology
Weight Management

Total
Visit
Encounters
N
15,562
258
132
412
576
37
11
66
491
1,590
301
1,134
711
194
997
74
695
641
110
466
200
1,134
92
80
255
1,326
93
293
1,734
234
153
247
306
199
147
173

The outcome measure of percent positive overall rating
was not significantly different between the two visit
modalities. The percent of telemedicine visits with a score
of 9 or 10 for overall rating of provider was 87.9%,
compared to 83.9% for in-person visits (p-value = 0.07).
(Figure 2) The telemedicine top box responses for the
person-centered measures were all statistically significantly
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Telemedicine Visit
Encounters
n
(% row total)
11,192
71.9%
247
95.7%
77
58.3%
362
87.9%
201
34.9%
34
91.9%
0
0.0%
0
0.0%
407
82.9%
1,582
99.5%
274
91.0%
1,015
89.5%
585
82.3%
171
88.1%
962
96.5%
51
68.9%
574
82.6%
74
11.5%
77
70.0%
249
53.4%
189
94.5%
1,057
93.2%
0
0.0%
76
95.0%
66
25.9%
369
27.8%
52
55.9%
205
70.0%
1,066
61.5%
217
92.7%
119
77.8%
186
75.3%
304
99.3%
83
41.7%
91
61.9%
170
98.3%

Encounters
In-Person Visits
n
(% row total)
4,370
28.1%
11
4.3%
55
41.7%
50
12.1%
375
65.1%
3
8.1%
11
100.0%
66
100.0%
84
17.1%
8
0.5%
27
9.0%
119
10.5%
126
17.7%
23
11.9%
35
3.5%
23
31.1%
121
17.4%
567
88.5%
33
30.0%
217
46.6%
11
5.5%
77
6.8%
92
100.0%
4
5.0%
189
74.1%
957
72.2%
41
44.1%
88
30.0%
668
38.5%
17
7.3%
34
22.2%
61
24.7%
2
0.7%
116
58.3%
56
38.1%
3
1.7%

higher than in-person visit responses including getting
enough information (80.6%, 75.7%, p-value < 0.05), active
listening (86.6%, 79.7%, p-value < 0.05), trust in the
provider (86.7%, 78.5%, p-value < 0.001) and knowledge
of the child’s medical history (78.9%, 58.9%, p-value <
0.0001). The process measures of timeliness of care
(70.4% telemedicine, 66.2% in-person, p-value = 0.12) was

Patient Experience Journal, Volume 7, Issue 2 – 2020

The rapid increase in telemedicine visits during COVID-19, Johnson et al.

not statistically different, but knowing what to do if they
had questions (78.6% telemedicine, 73.0% in-person, pvalue <0.05) did score statistically significantly higher for
telemedicine visits.

The two telemedicine modality questions are reported in
Figure 3. The top box response for telemedicine visit
process metrics of ease of use of the telemedicine platform
was 63.9%. The likelihood to recommend for telemedicine
was 74.3%.

Table 2. Variability in survey return data by visit type and specialty, April 15 – May 12, 2020
Surveys Returned
Surveys Returned
Telemedicine Visits
In-Person Clinic Visits
n
Return rate
n
Return rate
Subspecialty Care - Total
628
29.20%
603
26.10%
ADHD
18
26.50%
0
N/A (0)
Adolescent Specialty
0
N/A (0)
4
15.40%
Allergy
12
26.10%
8
26.70%
Cardiology
3
23.10%
68
27.10%
Child & Family Therapy
3
30.00%
0
0.0% (1)
Cystic Fibrosis
0
N/A (0)
1
14.30%
Dental
0
N/A (0)
8
16.30%
Dermatology
45
30.40%
18
28.60%
Developmental & Behavioral
117
27.70%
3
16.70%
Eating Disorders
0
N/A (0)
0
N/A (0)
Endocrine
50
29.90%
33
24.80%
ENT
3
23.10%
22
25.60%
Genetics
6
22.20%
5
26.30%
GI
73
26.00%
6
22.20%
Gynecology
2
33.30%
4
23.50%
Hearing & Speech
40
29.60%
24
20.30%
Hematology/Oncology
0
N/A (0)
29
27.40%
Infectious Diseases
1
14.30%
3
17.60%
Nephrology
6
25.00%
14
20.30%
Neonatal Follow-Up
11
21.60%
0
0.0% (5)
Neurology
126
33.20%
7
12.10%
Neurosurgery
0
N/A (0)
6
22.20%
Nutrition
7
43.80%
2
25.00%
Ophthalmology
0
N/A (0)
28
23.50%
Orthopedics
33
27.50%
157
27.20%
Pain Management
0
N/A (0)
0
0.0% (1)
Plastic Surgery
1
25.00%
12
30.00%
PT/OT
0
N/A (0)
34
25.40%
Pulmonology
12
26.70%
1
11.10%
Rehabilitation Medicine
8
27.60%
3
10.70%
Rheumatology
26
41.90%
11
23.90%
Sleep
0
N/A (0)
0
N/A (0)
Surgery
2
40.00%
84
38.40%
Urology
2
28.60%
6
37.50%
Weight Management
21
33.30%
2
33.30%
If no surveys were sent the value is expressed as N/A (0). If a survey was sent, but none were returned the value is expressed
as 0% (number of surveys sent).
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Figure 2. Overall and process measure positive response ratings
100%

**

90%

*
*

80%

***
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70%

60%
50%
40%
30%
20%
10%
0%
Rating of
provider

Trust
Did care
Got enough Care provider Knew what to Seen in timely
providers w/ provider listen
info re:
knew history do if questions
manner
care
treatment
Telehome

In Person

For each measure, percent positive (score of 9 or 10 for rating of provider or “Yes, definitely” for other process measures)
shown in blue for telehealth visits and orange for in-person clinic visits. Each measure with a statistically significant higher
rating for telehealth visit versus in-patient clinic visits are denoted with (*p<0.05), (**p<0.001), or (***p<0.0001).

Figure 3. Distribution of ratings for telehealth visit process measures

Figure on left: Raw scores on a 0-10 scale for likelihood of recommending telehealth to friends or family were
placed into three categories: Promoter (9-10), Neutral (7-8), and Detractor (0-6). Figure on right: Survey
responses about ease of using the telehealth platform was scored on a 4-point Likert scale: Yes, definitely; Yes,
mostly; Yes, somewhat, or No.

77

Patient Experience Journal, Volume 7, Issue 2 – 2020

The rapid increase in telemedicine visits during COVID-19, Johnson et al.

Discussion
The direct to patient telemedicine modality for pediatric
subspecialty visits at a tertiary children’s hospital was wellreceived by the population served. The overall rating for
the telemedicine encounters was higher than the in-person
visits, although not statistically significant. It would make
sense that the null hypothesis should not be rejected, as
the outcome measure was rating of the provider. The
telemedicine encounters and in-person encounters are
largely from the same pool of people. For example, the
same neurologist or endocrinologist could conduct both
in-person and telemedicine visits. Therefore, it would be
impressive to see rating of provider differ significantly
between the two modalities. The higher provider rating for
the telemedicine visit may be supported by the statistically
significantly higher person-centered metrics of the
telemedicine visits.
Our study was comprised of pediatric specialty patients
seen either by telemedicine or in-person visits and the
telemedicine cohort rated their experience equal to or
better than in-person visits. Several recent studies found
similarly high rates of patient satisfaction with telemedicine
encounters. A study of telemedicine care by Massachusetts
General Hospital showed that “nearly all [patients]
perceived the quality of care or communication to be the
same or better than at the traditional and familiar office
visits.”5 When combining the response options of quality
of care via telehealth, 83% of respondents reported it
being the same (62%) or higher (21%) than as an inperson visit.5 Looking at pediatric specific telehealth,
Atanda et al. found that 90% of pediatric sports medicine
patients were satisfied with telemedicine care, saved an
average of $50 per visit and regained over an hour in total
wait and visit time.6 Our tertiary children’s hospital cares
for a large encatchment area, mostly rural. A previous
study by Walsh and Markus found patients who lived
farther from the medical campus were more likely to
schedule a telemedicine visit.7 They also found no
statistically significant difference in any outcome measure
between telemedicine and in-person visits for their
population of patients with rare neurological disease, other
than telemedicine visits were shorter by an average of 3.4
minutes (p=0.01).7 In the Donelan et al. study, 79% of the
study participants found it easier to schedule a follow up
visit via telemedicine at a convenient time compared to an
in-person clinic visit at Massachusetts General Hospital. 5
Convenience, time savings, financial savings and better
access to care are likely reasons patients rate telemedicine
highly. In this study of pediatric specialty visits, the
modality of patient visit was not the patient or family’s
choice, rather the provider determined which previously
scheduled in-person visits could be converted to
telemedicine, which encounters required maintaining the
previously scheduled in-person visit, and which visits
needed to remain in-person but could be postponed to a
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later date to better accommodate the patient, family and
staff’s safety.
One would think that an in-person encounter would lead
to a more ‘personal’ experience. However, all the personcentered measures were statistically significantly higher in
the telemedicine visit. Even though they were conducted
through a screen, the telemedicine encounters led to
perceptions that the provider was more engaged during
the encounter. The most impressive difference being the
20% increase in perception that the provider knew the
patient’s history during telemedicine visits. It is unknown
whether the provider prepared more for telemedicine
visits, such as reviewing the chart prior to initiating the
virtual encounter. Most providers had decreased patient
visit loads during the study period (Figure 1) which may
have led to more time to prepare for the visits. The
providers may have had easier access to the chart during
the encounter, verbalizing their review of the chart. The
patients seen via telemedicine may have been patients
more familiar to the providers, as less first-time
consultations were conducted via telemedicine due to the
telemedicine scheduling guidelines for the institution.
Even though the person-centered measures scored higher
in telemedicine compared to in-person visits, the process
measures showed recommendation for the modality was
still only 74.3%, potentially influenced by the telemedicine
ease of use score at a meek 63.9%. Perception of
timeliness of the visit was not statistically significantly
different between telemedicine (70.4%) and in-person
visits (66.2%) and was the lowest-scored shared process
measure. While telemedicine removed some of the
burdens to receiving in-person care, the flow of the new
modality of telemedicine was still a barrier to the perfect
patient experience. The quick ramp up (Figure 1) in use of
direct-to-patient telemedicine may have led to variability in
quality of care delivery experience. Indeed, the subspecialty
clinics had variability in their prevalence of telemedicine
use (Table 1) and their previous experience conducting
facilitated telehealth visits. Monitoring patient experience
feedback for telemedicine visits will be imperative as the
institution continues to refine the delivery mechanics over
this new modality for providers.
There are limitations to this preliminary data. The data
only represent a four-week period, and sentiment about
medical care may be different during a pandemic. This
data is only from pediatric subspecialty ambulatory visits
and may not be applicable to adult visits, ancillary services,
or urgent/emergent visits. The information technology
support and platform used by this institution may not be
available in other settings, nor may be the preferred
platform. While response rates were similar between inperson and telemedicine in the 20% range, the impact of
response bias or demographic difference of the two
populations or respondents versus non-respondents is not
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known. It is important to recognize that socioeconomic
differences may also impact certain patient population
abilities to interact with care teams via telemedicine.

6.

Conclusion
In this pediatric health care entity, families rated direct to
patient telemedicine visits for pediatric subspecialty visits
not statistically different than in-person visits during the
COVID-19 pandemic. Even though they were physically
distant from their provider, patients and families reported
better experience across every person-centered process
measure compared to in-person visits. While the timeliness
of the visit rating was better with telemedicine, it was not
statistically significantly different and continues to be one
of the lowest scoring process measures for the clinic
specialties. Interestingly, respondents felt the providers
knew the patient’s history more when the encounter was
conducted via telemedicine. With the short study duration,
it is unknown whether these results will be sustained or
what the standard for clinic visits will be when the clinic
spaces can accommodate more patient visits in-person.
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